M. Alghazali, A. Löfgren, N. Cheng, K. Fagerlund, and A. Bjartell, “Update on a real-world study evaluating overall survival and treatment duration in Swedish patients with metastatic castration-resistant prostate cancer treated with enzalutamide”, SJU, vol. 54, no. 3, pp. 263–264, Mar. 2020.